# Awesome-SEND


## Links
- [CDISC](https://www.cdisc.org/standards/foundational/send)


## Tools

- [sendigR](https://github.com/phuse-org/sendigR) - Enable Cross-Study Analysis of CDISC SEND Datasets
- [SENDsanitizer](https://github.com/sbutler5/SENDsanitizer)
- [xptcleaner](https://pypi.org/project/xptcleaner/)
- [haven](https://github.com/tidyverse/haven)
- [read xpt file](https://haven.tidyverse.org/reference/read_xpt.html)

## Guidance
- [FDA Guidance - Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers](https://www.fda.gov/media/72309/download)

- [ICH - guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceutical M3(R2)](https://database.ich.org/sites/default/files/M3_R2__Guideline.pdf)
- [FDA - M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals](https://www.fda.gov/media/71542/download)

#### SEND Related paper
- [Making sense of SEND; the Standard for Exchange of Nonclinical Data](https://pubmed.ncbi.nlm.nih.gov/29066334/)
- [The Standard for the Exchange of Nonclinical Data (SEND): Challenges and Promises](https://pubmed.ncbi.nlm.nih.gov/30295163/)
- [Leveraging the Value of CDISC SEND Data Sets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals](https://pubs.acs.org/doi/10.1021/acs.chemrestox.0c00317)
- [SEND harmonization & cross-study analysis: A proposal to better harvest the value from SEND data](https://www.sciencedirect.com/science/article/pii/S027323001930306X?via%3Dihub)

## Books


## Blogs
- [sensiblesend from Marc Ellison](https://sensiblesend.blog/)

## YouTube
- [Overview of Non-clinical Assessment in Drug Development](https://www.youtube.com/watch?v=oG1_NYcgy3c&ab_channel=U.S.FoodandDrugAdministration)
- [Most Common Issues with CDISC-SEND Data in FDA Toxicology Review](https://www.youtube.com/watch?v=-PibvzF2p4Y&ab_channel=U.S.FoodandDrugAdministration)
